You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

35 search results for: guidelines

ERS-ISIAN 2023 | Implementation of <b>Guidelines</b> into Daily Practice: Past, Present, and Future
expert video

ERS-ISIAN 2023 | Implementation of Guidelines into Daily Practice: Past, Present, and Future

Rhinology
Dr. Stella Lee explores the past, present and future implementation of guidelines into daily practice
View more
New Horizons: The Emergence of Targeted Therapies
expert video

New Horizons: The Emergence of Targeted Therapies

Dermatology
In this ADVENT symposium at the 2024 EADV meeting, Professor Dedee Murrell reviews the current treatment guidelines for bullous pemphigoid (BP) and the emergence of targeted therapies including a highlight of the LIBERTY-BP ADEPT interim results.
View more
Eosinophilic Esophagitis (EoE) Interactive Patient Case
interactivity

Eosinophilic Esophagitis (EoE) Interactive Patient Case

Gastroenterology
Learn about the guidelines for diagnosis, treatment options, and criteria for treatment response in EoE through the journey of a hypothetical EoE patient
View more
Type 2 Inflammation Digital Assessment Tool
interactivity

Type 2 Inflammation Digital Assessment Tool

Pulmonology
Learn how to assess patients for the presence of uncontrolled asthma driven by underlying type 2 inflammation.
View more
GINA-Based Opportunities for Improved Outcomes With Effective Management of Pediatric Asthma in Children 6-11 Years of Age
interactivity

GINA-Based Opportunities for Improved Outcomes With Effective Management of Pediatric Asthma in Children 6-11 Years of Age

Pulmonology
Explore GINA-based recommendations for identifying risk factors, optimizing management plans, and monitoring disease progression in pediatric asthma.
View more
ERS 2023 | Advancing Asthma Management Beyond Control
expert video

ERS 2023 | Advancing Asthma Management Beyond Control

Pulmonology
Prof. Ian Pavord discusses the current proposed framework for clinical remission in severe asthma.
View more
Chronic Spontaneous Urticaria (CSU) Interactive Patient Case
interactivity

Chronic Spontaneous Urticaria (CSU) Interactive Patient Case

Dermatology
Learn more about the guideline-based diagnosis of chronic spontaneous urticaria with this interactive patient case.
View more
GOLD 2024 Diagnosis and Assessment of COPD
expert video

GOLD 2024 Diagnosis and Assessment of COPD

Pulmonology
This short video presentation outlines the diagnosis and assessment of COPD according to the 2024 GOLD report, focusing on clinical features and assessment goals.
View more
GOLD 2024 Diagnosis and Assessment of COPD
videoanimation

GOLD 2024 Diagnosis and Assessment of COPD

Pulmonology
This short video presentation outlines the diagnosis and assessment of COPD according to the 2024 GOLD report, focusing on clinical features and assessment goals.
View more
COPD and Asthma: What's the Difference and Is There a Link?
interactivity

COPD and Asthma: What's the Difference and Is There a Link?

Pulmonology
Explore the characteristics of COPD and asthma, focusing on their shared inflammatory mechanisms and key clinical differences.
View more
ERS 2023 | Evolving Patient Care: From Symptom Control to On-Treatment ​Clinical Remission​
expert video

ERS 2023 | Evolving Patient Care: From Symptom Control to On-Treatment ​Clinical Remission​

Pulmonology
Join Profs. Ian Pavord and Vibeke Backer and Dr. Francesca Puggioni for an educational program on the topic of clinical remission in severe asthma.
View more
On-Treatment Asthma Remission: Moving Beyond Control
interactivity

On-Treatment Asthma Remission: Moving Beyond Control

Pulmonology
Learn about the proposed framework for clinical remission in patients with asthma
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ItalyChange country/region